|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,056,670 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$64,995,519 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 22 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-04-29 |
4 |
A |
$62.41 |
$21,281 |
D/D |
341 |
335,324 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-06-04 |
4 |
S |
$62.52 |
$62,521 |
D/D |
(1,000) |
178,257 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-04-30 |
4 |
A |
$62.59 |
$21,217 |
D/D |
339 |
298,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-10-31 |
4 |
AS |
$62.72 |
$627,155 |
I/I |
(10,000) |
45,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2023-12-21 |
4 |
OE |
$63.10 |
$631,000 |
D/D |
10,000 |
435,112 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-01-09 |
4 |
OE |
$63.10 |
$631,000 |
D/D |
10,000 |
435,162 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-01-10 |
4 |
OE |
$63.10 |
$631,000 |
D/D |
10,000 |
435,162 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-08 |
4 |
OE |
$63.10 |
$946,500 |
D/D |
15,000 |
434,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-02-09 |
4 |
OE |
$63.10 |
$946,500 |
D/D |
15,000 |
434,602 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-04-11 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-04-12 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-05-09 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2024-05-10 |
4 |
OE |
$63.10 |
$1,262,000 |
D/D |
20,000 |
494,994 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2018-12-31 |
4 |
A |
$63.59 |
$14,499 |
D/D |
228 |
6,896 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-07-15 |
4 |
OE |
$63.70 |
$63,698 |
I/I |
1,000 |
48,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-04-30 |
4 |
S |
$63.74 |
$63,742 |
D/D |
(1,000) |
119,317 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-17 |
4 |
OE |
$64.01 |
$320,050 |
I/I |
5,000 |
30,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-21 |
4 |
AS |
$64.14 |
$128,279 |
I/I |
(2,000) |
30,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-08-15 |
4 |
S |
$64.36 |
$64,364 |
I/I |
(1,000) |
48,740 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-16 |
4 |
AS |
$64.65 |
$129,307 |
I/I |
(2,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-08 |
4 |
D |
$65.32 |
$357,888 |
D/D |
(5,479) |
112,838 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-02 |
4 |
S |
$65.62 |
$131,241 |
I/I |
(2,000) |
13,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-07 |
4 |
AS |
$65.87 |
$197,613 |
I/I |
(3,000) |
13,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-08 |
4 |
AS |
$65.88 |
$65,879 |
D/D |
(1,000) |
118,317 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-10-10 |
4 |
AS |
$66.76 |
$200,291 |
I/I |
(3,000) |
45,740 |
0 |
- |
|
852 Records found
|
|
Page 22 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|